Torbjørn Omland Selected Research

Viremia

12/2021	Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity.
1/2021	SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.
12/2020	Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Torbjørn Omland Research Topics

Disease

86	Heart Failure 04/2024 - 05/2002
30	Myocardial Infarction 12/2023 - 01/2003
29	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 01/2005
24	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 01/2005
24	Acute Coronary Syndrome 11/2023 - 02/2002
19	Dyspnea (Shortness of Breath) 01/2023 - 07/2002
17	Chronic Obstructive Pulmonary Disease (COPD) 08/2023 - 09/2008
13	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2008
12	COVID-19 04/2024 - 06/2020
11	Inflammation (Inflammations) 01/2021 - 12/2005
9	Hypertension (High Blood Pressure) 04/2024 - 11/2006
9	Obstructive Sleep Apnea 10/2022 - 06/2011
8	Chest Pain (Chest Pains) 12/2023 - 01/2005
8	Left Ventricular Dysfunction 01/2021 - 08/2003
8	Sepsis (Septicemia) 12/2020 - 01/2008
7	Atherosclerosis 01/2024 - 08/2005
7	Obesity 12/2022 - 11/2004
6	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2012
6	Weight Loss (Weight Reduction) 12/2022 - 05/2013
6	Neoplasms (Cancer) 03/2022 - 11/2004
6	Coronary Disease (Coronary Heart Disease) 07/2015 - 01/2005
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 04/2024 - 06/2007
5	Heart Diseases (Heart Disease) 01/2022 - 03/2010
4	Ventricular Tachycardia 12/2023 - 01/2016
4	Infarction (Infarctions) 01/2023 - 07/2009
4	Atrial Fibrillation 01/2023 - 06/2005
4	Hypoxia (Hypoxemia) 11/2022 - 01/2008
4	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 10/2016
4	Sleep Apnea Syndromes (Sleep Apnea) 10/2022 - 03/2013
4	Non-ST Elevated Myocardial Infarction 03/2022 - 10/2019
4	Ischemia 01/2022 - 01/2005
4	Ischemic Stroke 07/2021 - 02/2014
4	Diabetes Mellitus 01/2021 - 11/2006
4	Morbid Obesity 12/2020 - 09/2011
4	Cardiac Arrhythmias (Arrythmia) 01/2019 - 01/2008
3	Second Primary Neoplasms (Neoplasms, Second) 02/2024 - 01/2021
3	Viremia 12/2021 - 12/2020
3	Ventricular Remodeling 01/2021 - 01/2018
3	Aortic Valve Stenosis (Aortic Stenosis) 01/2021 - 07/2011
3	Out-of-Hospital Cardiac Arrest 01/2020 - 11/2014
3	Shock 01/2018 - 01/2008
3	Major Depressive Disorder (Major Depressive Disorders) 03/2013 - 06/2011
3	Renal Insufficiency (Renal Failure) 10/2009 - 11/2005
3	Anemia 10/2009 - 11/2005
2	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2023 - 10/2021
2	Cicatrix (Scar) 01/2023 - 12/2021
2	Cardiotoxicity 03/2022 - 12/2020
2	Overweight 01/2022 - 05/2006
2	Fatigue 01/2022 - 01/2020
2	Unstable Angina 01/2022 - 04/2020

Drug/Important Bio-Agent (IBA)

62	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024 - 02/2002
59	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2005
40	Troponin T (Troponin T1)IBA 04/2024 - 07/2009
36	pro-brain natriuretic peptide (1-76)IBA 01/2024 - 01/2003
35	TroponinIBA 04/2024 - 11/2012
19	Troponin IIBA 04/2024 - 11/2012
13	secretoneurinIBA 04/2024 - 01/2012
13	trans-crotonin (CTN)IBA 02/2024 - 05/2013
13	C-Reactive ProteinIBA 01/2021 - 08/2005
11	OsteoprotegerinIBA 01/2016 - 11/2004
9	Natriuretic PeptidesIBA 12/2020 - 07/2002
9	Chromogranin AIBA 12/2017 - 01/2003
8	CreatinineIBA 01/2021 - 07/2005
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2010
7	AnthracyclinesIBA 03/2022 - 01/2016
7	Indicators and Reagents (Reagents)IBA 01/2020 - 09/2004
5	LipidsIBA 10/2023 - 06/2011
5	Trinitrotoluene (TNT)IBA 01/2019 - 07/2011
4	MicroRNAs (MicroRNA)IBA 10/2023 - 01/2016
4	CytokinesIBA 01/2023 - 12/2005
4	Growth Differentiation Factor 15IBA 01/2023 - 12/2020
4	Oxygen (Dioxygen)IBA 01/2023 - 01/2013
4	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2021 - 01/2016
4	candesartanIBA 01/2021 - 01/2016
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2014 - 07/2005
4	DiureticsIBA 02/2008 - 05/2002
3	GadoliniumIBA 04/2024 - 12/2021
3	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 09/2011
3	candesartan cilexetil (Amias)FDA Link 01/2021 - 01/2016
3	ProcalcitoninIBA 01/2021 - 09/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2013
3	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2012
3	Trastuzumab (Herceptin)FDA Link 12/2020 - 01/2012
3	CholesterolIBA 12/2019 - 01/2013
3	AdiponectinIBA 04/2018 - 12/2011
3	Epirubicin (Ellence)FDA LinkGeneric 01/2018 - 01/2012
3	Hemoglobins (Hemoglobin)IBA 07/2009 - 06/2005
2	InterferonsIBA 08/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	PlacebosIBA 01/2021 - 01/2016
2	Ferritins (Ferritin)IBA 01/2021 - 12/2020
2	EnzymesIBA 01/2021 - 08/2015
2	fibrin fragment D (D-dimer)IBA 01/2021 - 12/2020

Therapy/Procedure

19	Therapeutics 02/2024 - 05/2002
4	Gastric Bypass (Roux-en-Y Gastric Bypass) 12/2020 - 05/2013
3	Bariatric Surgery 12/2022 - 09/2011
3	Radiotherapy 01/2021 - 01/2012
2	Length of Stay 12/2023 - 01/2023
2	Percutaneous Coronary Intervention 10/2023 - 08/2005
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2012